Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of nebivolol on the nitric oxide system in patients with essential hypertension
2012-001131-31Phase 2Completed
- Sponsor
- Department of Medical Research
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of nebivolol in essential hypertension, sponsored by Department of Medical Research. Primary endpoint: Fractional excretion of sodium (FENa). Started Jun 2012; status: completed.
02
Drugs
nebivolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2012-001131-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001131-31.